Merck’s $6.7B Terns Acquisition Positions It to Challenge a Blockbuster Novartis Cancer DrugNews DeskMarch 25, 20260 Merck is picking up a big new piece for its cancer drug pipeline with a $6.7 billion deal to acquire…